Powered by

WilmerHale Advises Argos Therapeutics in Asset Sale to Affiliate of SCM Lifescience and Genexine

Mar 12, 2019 - Targeted News Service

WilmerHale, a law firm, issued the following news:

WilmerHale acted as lead counsel to immunotherapy company Argos Therapeutics, Inc. (OTCPK: ARGS.Q) in the sale of substantially all of its assets to an affiliate of SCM Lifescience Co., Ltd. and Genexine, Inc.

After two decades of refining its technology, Argos faced liquidity challenges in continuing its intellectual property development mission. In order to preserve the value of its assets, Argos filed for Chapter 11 bankruptcy in ...